Afferent Pharmaceuticals (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- July 09, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $55,000,000
Company Info
- Company Description
- Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.
- Market
- Neurogenic disorders
- Location
- San Mateo, California, USA
- Coinvestors
- Fidelity Management & Research Company, Jennison Associates, New Leaf Venture Partners, Partner Fund Management, Redmile Group, Tekla Healthcare Investors, Tekla Life Science Investors